🔴 Lantern Pharma is trading 11% down today with no clear company-specific negative catalyst identified

Lantern Pharma is trading 11% down now at $1.72, with no clear company-specific negative catalyst identified.

• The September 16, 2026, rally has reversed.
• The September 17 announcement about a September 23 Open-Medicine AI webinar is forward-looking and does not explain the decline.
• The broader market and biotechnology sector are rising, so they do not directly account for the isolated drop.